AzTrials
AzTrials

Anesthesia for Laparoscopic HysterectomyEGA-LHNCT07847801

Epidural Versus General Anesthesia for Laparoscopic Hysterectomy

A study testing epidural anesthesia and General Anesthesia (GA) in people with Anesthesia for Laparoscopic Hysterectomy, run by Sabiha Başarı at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized controlled study will compare epidural anesthesia with general anesthesia in women undergoing elective laparoscopic hysterectomy. A total of 70 participants will be randomly assigned to receive either epidural anesthesia or general anesthesia. Read more about this study

Who is it for?
Ages 18 to 70 years, women only
Conditions the study is for
Anesthesia for Laparoscopic Hysterectomy
What is being tested?
epidural anesthesia and General Anesthesia (GA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
70 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 Oct 2026to 22 Oct 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female patients aged 18-70 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body mass index (BMI) ≤30 kg/m²
  • Scheduled for elective laparoscopic total hysterectomy
  • Willing and able to provide informed consent

Who cannot join

  • Contraindication to neuraxial anesthesia
  • Severe cardiopulmonary disease
  • BMI >30 kg/m²
  • Pre-existing neurological disorder
  • Inability to cooperate with the study procedures
  • Refusal to participate in the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Sabiha Başarı, MD contact

+905446616686

sabihabasari0@gmail.com

Turkey (Türkiye)1 site
  • Kutahya City Hospital

    Kütahya, Kütahya, 43100

    Sabiha Başarı, MD, +905446616686, sabihabasari0@gmail.com

    sabihabasari0@gmail.com

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of the Effects of Epidural Anesthesia and General Anesthesia on Postoperative Respiratory Function and Pain in Laparoscopic Hysterectomy

This randomized controlled study will compare epidural anesthesia with general anesthesia in women undergoing elective laparoscopic hysterectomy. A total of 70 participants will be randomly assigned to receive either epidural anesthesia or general anesthesia.

The main aim of the study is to determine whether the type of anesthesia affects respiratory function after surgery. Respiratory function will primarily be assessed using peak expiratory flow rate (PEFR) before surgery and at 2, 6, and 24 hours after surgery.

Read more

The study will also compare postoperative pain, opioid consumption, respiratory and hemodynamic parameters, recovery, mobilization, and other perioperative outcomes between the two groups.

The researchers aim to determine whether epidural anesthesia may provide an alternative anesthetic approach for selected patients undergoing laparoscopic hysterectomy while maintaining spontaneous breathing.

Read the detailed description

This is a prospective, single-center, randomized, controlled, parallel-group study involving 70 adult women scheduled for elective laparoscopic total hysterectomy.

Participants will be randomly allocated in a 1:1 ratio to an epidural anesthesia group or a general anesthesia group. In the epidural anesthesia group, anesthesia will be provided through a lumbar epidural catheter, with spontaneous ventilation maintained. Sedation will be provided as required. In the general anesthesia group, anesthesia will be induced intravenously, followed by endotracheal intubation and controlled mechanical ventilation.

Respiratory function will be evaluated using peak expiratory flow rate (PEFR) before surgery and at 2, 6, and 24 hours after surgery. Postoperative pain scores, opioid consumption, respiratory and hemodynamic parameters, recovery characteristics, mobilization, and perioperative adverse events will also be evaluated.

Participants in the epidural anesthesia group may be converted to general anesthesia if the epidural block is inadequate, the participant cannot tolerate the procedure, or conversion is considered clinically necessary.

Being tested
epidural anesthesia, General Anesthesia (GA)
Keywords
Epidural Anesthesia, General Anesthesia, Laparoscopic Hysterectomy, Postoperative Respiratory Function, Peak Expiratory Flow Rate, Postoperative Pain, Opioid Consumption
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • epidural anesthesiaProcedure or surgery

    pidural anesthesia will be administered via a lumbar epidural catheter using 0.5% bupivacaine and fentanyl. Incremental epidural doses will be administered to achieve an adequate sensory block. Spontaneous ventilation will be maintained, and dexmedetomidine will be used for sedation.

  • General Anesthesia (GA)Procedure or surgery

    General anesthesia will be induced with intravenous propofol, fentanyl, and rocuronium, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation.

Study groups in NCT07847801
Study groupRoleWhat they receive
Epidural AnesthesiaExperimentalParticipants assigned to this arm will receive epidural anesthesia via a lumbar epidural catheter. An initial dose of 10 mL of 0.5% bupivacaine with 50 mcg fentanyl will be administered, followed by incremental doses of 2-3 mL of 0.5% bupivacaine every 5 minutes as required to achieve a T4 sensory block, up to approximately 20 mL. Spontaneous ventilation will be maintained. Dexmedetomidine will be administered at 0.2 mcg/kg/h for sedation. Conversion to general anesthesia will be performed if the epidural block is inadequate, the participant cannot tolerate the procedure, or conversion is clinically required.
Receives: Procedure: epidural anesthesia
General AnesthesiaActive comparatorParticipants assigned to this arm will receive standard general anesthesia. Anesthesia will be induced with propofol 2-2.5 mg/kg, fentanyl 1-2 mcg/kg, and rocuronium 0.6 mg/kg, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation, with end-tidal carbon dioxide maintained between 35 and 40 mmHg.
Receives: Procedure: General Anesthesia (GA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Peak Expiratory Flow Rate (PEFR)

    Peak expiratory flow rate (PEFR), measured in liters per minute (L/min), will be assessed before surgery and at 2, 6, and 24 hours after surgery. The change in PEFR from the preoperative baseline will be compared between the epidural anesthesia and general anesthesia groups

    Measured: Preoperative baseline and 2, 6, and 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Sep 2026
  2. Study start22 Oct 2026 (estimated)
  3. Primary completion22 Oct 2027 (estimated)
  4. Study completion22 Oct 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned in a 1:1 ratio to either the epidural anesthesia group or the general anesthesia group. Each participant will receive only the intervention assigned to their group.
Masking
None (open label)
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07847801
Sponsor's protocol ID
KSH-ARKHD-001
Acronym
EGA-LH
Status last verified
Sep 2026
First submitted
23 Sep 2026
Last updated
29 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data that underlie the results reported in the published article may be shared upon reasonable request to the corresponding author.

Questions about this trial

What is this clinical trial studying?

A study testing epidural anesthesia and General Anesthesia (GA) in people with Anesthesia for Laparoscopic Hysterectomy, run by Sabiha Başarı at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 29 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sabiha Başarı, MD (+905446616686, sabihabasari0@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Peak Expiratory Flow Rate (PEFR) (time frame: Preoperative baseline and 2, 6, and 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in